LMAO!! James Cappellucci Sr. Grant Administrator, Grants & Contracts Partners Healthcare/Massachusetts General Hospital 101 Huntington Avenue, 3rd Floor, Suite 300 Boston, MA 02199 Phone 617-954-9858 Fax: 617-954-9850 Main: 617-954-9309 xxxxxx@partners.org -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Bloomberg, Robert Sent: Friday, April 17, 2009 1:03 PM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] ARRA Competing Revisions If Joseph Heller were writing Catch 22 now, he might have chosen g.g as his subject, not the military. Robert P. Bloomberg Director, Office of Grants & Contracts Tufts Medical Center 800 Washington Street (Tupper 10) Boston, MA 02111 Tel. 617.636.1142 Fax. 617.636.8568 > -----Original Message----- > From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf > Of Nolan, Linda J. > Sent: Friday, April 17, 2009 12:47 PM > To: xxxxxx@hrinet.org > Subject: Re: [RESADM-L] ARRA Competing Revisions > > Hmmm. I tried a resubmission after seeing this message, but now I get > an error that, "A resubmission (an amended application) cannot be > submitted if a prior version in the same support year has been awarded." > HUH??? > > Linda > > Linda J. Nolan, CRA > Coordinator, Policy & Funding > H. Lee Moffitt Cancer Ctr. & Research Institute > 12902 Magnolia Dr. MRC-RESADM > Tampa, FL 33612 > 813-745-6071 > xxxxxx@moffitt.org > > -----Original Message----- > From: Research Administration List [mailto:xxxxxx@hrinet.org] On > Behalf Of Beyea, Donna L. > Sent: Friday, April 17, 2009 9:24 AM > To: xxxxxx@hrinet.org > Subject: [RESADM-L] ARRA Competing Revisions > > We've not seen this specific error as yet. However, we have had several > rejected stating that the "parent grant is not funded". This apparently > is because the project end date for the revision request exceeded the > current end date on the parent grant. Even if you are requesting > funding that will continue the project into a future no-cost extension, > you have to only show the current dates of the grant (hence we had apps > going in for $400,000 for a five month period since we can't process an > extension as yet) > > Also, beware that NOT-09-079 is completely incorrect. If you are > submitting a Competitive Revision for an R21 that would now require a > detailed budget because the request exceeds the modular budget threshold > you will not get a "warning" as stated in the Notice. You get an > "error" and therefore you cannot submit at all - we are now trying to > manipulate the budget to fit on a modular budget form and will include > the detailed budget in the justification. > > I have tried contacting Grants.gov, Commons and Grantinfo but I have not > had any response to this major issue. > > Donna > ************************ > Donna L. Beyea > Assistant Director > Office of Research & Project Administration > 518 Hylan Building > Box 270140 > Rochester, NY 14627 > Phone: 585-275-8037 > Fax: 585-275-9492 > email: xxxxxx@rochester.edu > > > > -----Original Message----- > From: Research Administration List [mailto:xxxxxx@hrinet.org] On > Behalf Of William H. Ploog > Sent: Friday, April 17, 2009 8:52 AM > To: xxxxxx@hrinet.org > Subject: [RESADM-L] ARRA Competing Revisions > > Hi, > > We are trying to submit ARRA Competing Revisions (NIH) that are due on > the 21st and they are being rejected with an error that states either > that the application is a duplicate or that we need permission to submit > corrections. We have contacted the Grants.gov Help Desk and the Program > Officer as well as others who have been recommended by G.g or NIH, but > no one seems to have the definitive answer. The PI has also been in > touch with both the program officer and the help desk. Help Desk at > NIH thinks this is an IT problem -- anyone else experiencing this? > > thanks, > > Bill > > William Ploog, Ph.D. > Associate Director > Office of Sponsored Projects > Dartmouth College > 11 Rope Ferry Rd. #6210 > Hanover, NH 03755-1404 > > (603) 646-3682 > fax (603)646-3670 > > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > > > This transmission may be confidential or protected from disclosure and is > only for review and use by the intended recipient. Access by anyone else > is unauthorized. Any unauthorized reader is hereby notified that any > review, use, dissemination, disclosure or copying of this information, or > any act or omission taken in reliance on it, is prohibited and may be > unlawful. If you received this transmission in error, please notify the > sender immediately. Thank you. > > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== The information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Partners Compliance HelpLine at http://www.partners.org/complianceline . If the e-mail was sent to you in error but does not contain patient information, please contact the sender and properly dispose of the e-mail. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
